AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 22-A-03-023.06
FDA work with the Program Support Center to obtain from PRISM recurring reports used to facilitate contract closeout.
The recommendation, in the publisher's words
FDA work with the Program Support Center to obtain from PRISM recurring reports used to facilitate contract closeout.
- Responsible agency
- Food and Drug Administration
- Issued
- December 16, 2021
- Report
- The Food and Drug Administration Needs To Improve Its Contract Closeout Processes To Identify Contracts Eligible for Closeout and Close Contracts Timely (A-03-20-03004) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Closed
- March 12, 2026 (publisher's date)
- Publisher topics
- Contracts, Departmental Operational Issues, Financial Stewardship
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- Closed, with status “Closed Implemented”. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
5 more, of which 1 is open in the publisher's file.
- We recommend that the Food and Drug Administration deobligate $88,152 in contract funding and close the six contracts that remained open but eligible for closeout as of June 15, 2021.HHS OIG 22-A-03-023.01 · issued Dec 16, 2021 · closed Mar 11, 2024Closed Implemented
- We recommend that the FDA automate both the tracking of awards assigned to contract closeout staff for closeout and the process of sending closeout documents to the contractor and COR.HHS OIG 22-A-03-023.02 · issued Dec 16, 2021Open Unimplemented
- We recommend that the FDA add language to the contract awards to require that contractors specify when an invoice is the final contract invoice.HHS OIG 22-A-03-023.03 · issued Dec 16, 2021 · closed Mar 11, 2024Closed Implemented
- We recommend that the FDA require contracting officers and CORs to notify contract closeout specialists in a timely manner when a contract is physically complete.HHS OIG 22-A-03-023.04 · issued Dec 16, 2021 · closed Mar 11, 2024Closed Implemented
- FDA require that CORs communicate a change in COR to the contracting officer before the COR leaves the position.HHS OIG 22-A-03-023.05 · issued Dec 16, 2021 · closed Mar 11, 2024Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.